Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 2/20 | 0.75 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | PLG | P00747 | 1/20 | 0.51 |
| ▸ | F12 | P00748 | 1/20 | 0.51 |
| ▸ | F11 | P03951 | 1/20 | 0.51 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.51 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.51 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.51 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.51 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.45 |
| ▸ | CA4 | P22748 | 1/20 | 0.45 |
| ▸ | CA6 | P23280 | 1/20 | 0.45 |
| ▸ | CA5A | P35218 | 1/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.45 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31184179 | 1.00 | MGLL (0.75) | MGLLCA1CA2PLGF12 | |
| SCHEMBL24618481 | 0.97 | MGLL (0.70) | MGLLCA1CA2PLGF12 | |
| SCHEMBL30472537 | 0.97 | MGLL (0.70) | MGLLCA1CA2PLGF12 | |
| SCHEMBL23441721 | 0.97 | MGLL (0.70) | MGLLCA1CA2PLGF12 | |
| SCHEMBL18374495 | 0.96 | MGLL (0.69) | MGLLCA1CA2PLGF12 | |
| SCHEMBL32673209 | 0.96 | MGLL (0.69) | MGLLCA1CA2PLGF12 | |
| SCHEMBL22646624 | 0.95 | MGLL (0.72) | MGLLCA1CA2PLGF12 | |
| SCHEMBL26815282 | 0.94 | MGLL (0.66) | MGLLCA1CA2PLGF12 | |
| SCHEMBL30526047 | 0.93 | MGLL (0.69) | MGLLCA1CA2PLGF12 | |
| SCHEMBL19006630 | 0.93 | MGLL (0.69) | MGLLCA1CA2PLGF12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3831831-B1 | ORGANIC COMPOUND CONTAINING HETEROCYCLIC RING AND HAVING LOW LUMO PROPERTIES, AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2024-05-01 | — | — | EP | disclosed |
| US-11690289-B2 | Organic compound containing heterocyclic ring and having low lumo properties, and organic electroluminescent device using the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-06-27 | — | — | US | disclosed |
| EP-3831831-A1 | ORGANIC COMPOUND CONTAINING HETEROCYCLIC RING AND HAVING LOW LUMO PROPERTIES, AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | Samsung Display Co., Ltd. (KR) | 2021-06-09 | — | — | EP | disclosed |
| CN-112898294-A | Heterocyclic compound and organic electroluminescent device using the same | 三星显示有限公司 | 2021-06-04 | — | — | CN | disclosed |
| US-20210167296-A1 | ORGANIC COMPOUND CONTAINING HETEROCYCLIC RING AND HAVING LOW LUMO PROPERTIES, AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2021-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11690289-B2 | Organic compound containing heterocyclic ring and having low lumo properties, and organic electroluminescent device using the same | LEF1, PPOX, LIMK1 | MGLL 2548/4885CA1 3841/4885CA2 2875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.